Elevated Senescence Markers in Developing Trisomy 21 Human Lungs
- PMID: 40019852
- PMCID: PMC12334841
- DOI: 10.1165/rcmb.2024-0361OC
Elevated Senescence Markers in Developing Trisomy 21 Human Lungs
Abstract
Human chromosomal anomalies, notably trisomies, disrupt gene expression, leading to diverse cellular and organ phenotypes. Increased cellular senescence (SEN) and oxidative stress in trisomies have gained recent attention. We assessed SEN, SEN-associated secretory phenotype (SASP), and oxidative stress on trisomy 13 (T13), T18, and T21 human fetal lung tissues and isolated primary human fetal lung fibroblasts. Telomerase-associated foci staining showed DNA damage primarily within T21 and T18 lungs. These results were confirmed by real-time quantitative PCR showing an increase of the SEN marker CDKN2B and SASP markers IL-6 and CXCL8. In contrast, lung tissues from T13 showed an upregulation of CDKN2A, whereas no significant changes in SASP marker genes were observed. γ-H2AX (H2A histone family member X) was upregulated in each genotype, particularly in T21. Isolated fibroblasts demonstrated a strong association between T21 and several SEN markers. An increase of γ-H2AX-positive cells were observed in fibroblasts from T21, T18, and T13, but only T21 exhibited an increase in P21 expression. Only T21 fibroblasts displayed a significant increase in reactive oxygen species levels, as indicated by MitoSOX and CellROX. This study provides the first evidence of a link between SEN and trisomy anomalies during prenatal human lung development, particularly in T21.
Keywords: Down syndrome; lung development; senescence; trisomy.
Comment in
-
Senescence at the Crossroads of Lung Development and Injury.Am J Respir Cell Mol Biol. 2025 Aug;73(2):161-162. doi: 10.1165/rcmb.2024-0564ED. Am J Respir Cell Mol Biol. 2025. PMID: 40153604 Free PMC article. No abstract available.
References
-
- Desai SS. Down syndrome: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 1997;84:279–285. - PubMed
-
- Freeman SB, Taft LF, Dooley KJ, Allran K, Sherman SL, Hassold TJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet . 1998;80:213–217. - PubMed
-
- McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr . 2011;158:319–325. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
